Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Citi
Express Scripts
Dow
Federal Trade Commission
Argus Health
Fish and Richardson
Accenture
Queensland Health
Fuji

Generated: February 18, 2018

DrugPatentWatch Database Preview

Ranitidine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ranitidine hydrochloride and what is the scope of ranitidine hydrochloride patent protection?

Ranitidine hydrochloride
is the generic ingredient in seven branded drugs marketed by Dr Reddys Labs Ltd, Mylan, Sandoz, Teva, Glaxosmithkline, Glaxo Grp Ltd, Bedford, Mylan Labs Ltd, West-ward Pharms Int, Zydus Pharms Usa Inc, Teligent, Actavis Mid Atlantic, Amneal Pharms, Apotex Inc, Aurobindo Pharma Ltd, Bio Pharm Inc, Breckenridge Pharm, Hi Tech Pharma, Nostrum Labs Inc, Pharm Assoc, Ranbaxy, Silarx, Taro, Tolmar, Vintage Pharms, Wockhardt, Sanofi Us, Acic Pharms, Amneal Pharms Ny, Apotex, Boehringer Ingelheim, Contract Pharmacal, Dr Reddys Labs Inc, Glenmark Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Perrigo, Perrigo R And D, Strides Pharma, Sun Pharm Inds Ltd, Watson Labs, Watson Labs Inc, and Wockhardt Ltd, and is included in seventy-three NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-three drug master file entries for ranitidine hydrochloride. One hundred and forty-three suppliers are listed for this compound. There are two tentative approvals for this compound.
Pharmacology for ranitidine hydrochloride
Tentative approvals for RANITIDINE HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free TrialEQ 150MG BASETABLET;ORAL
➤ Try a Free Trial➤ Try a Free TrialEQ 300MG BASETABLET;ORAL
➤ Try a Free Trial➤ Try a Free TrialEQ 25MG BASE/MLINJECTABLE;INJECTION

US Patents and Regulatory Information for ranitidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 075000-002 Jan 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wockhardt RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 078653-001 Nov 26, 2007 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex Inc RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 075167-001 May 4, 2000 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 075296-001 Jan 14, 2000 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 075165-001 Sep 30, 1998 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 075439-002 Apr 19, 2000 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wockhardt Ltd RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 075208-001 Dec 17, 1998 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Strides Pharma RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 201745-001 Feb 29, 2012 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Assoc RANITIDINE HYDROCHLORIDE ranitidine hydrochloride SYRUP;ORAL 077405-001 Sep 21, 2007 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ranitidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline ZANTAC 300 ranitidine hydrochloride CAPSULE;ORAL 020095-002 Mar 8, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride TABLET, EFFERVESCENT;ORAL 020251-001 Mar 31, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-001 Dec 17, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-001 Dec 17, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Us ZANTAC 150 ranitidine hydrochloride TABLET;ORAL 021698-002 Mar 13, 2007 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline ZANTAC 150 ranitidine hydrochloride CAPSULE;ORAL 020095-001 Mar 8, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
US Department of Justice
Boehringer Ingelheim
Farmers Insurance
Johnson and Johnson
Deloitte
Harvard Business School
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot